Skip to content

Reassessing the Amyloid-Neurodegeneration Relationship: Integrating Demographic and Amyloid PET Measures to Estimate AD-Related Glucose Hypometabolism.

Oct 2026 · Current Alzheimer Research · 0 citations
Medicine

Abstract

INTRODUCTION The relationship between amyloid deposition and neurodegeneration in Alzheimer's Disease (AD) remains incompletely understood. Previous studies have indicated that using a cerebral white matter reference region for amyloid PET Standardized Uptake Value Ratio (SUVR) calculation strengthens the association compared with the commonly used cerebellar reference region. This study examined whether amyloid PET measures, when integrated with demographic information, can further enhance the estimate of the AD-related glucose hypometabolism, measured by the FDG-PET Hypometabolic Convergence Index (HCI), and whether this relationship is stronger when amyloid burden is quantified using a cerebral white matter reference region rather than a cerebellar reference region.

Materials And Methods

Baseline ADNI data from 1,133 participants, including cognitively unimpaired individuals, participants with mild cognitive impairment, and patients with AD, were analyzed. HCI was used as the outcome measure of AD-related glucose hypometabolism. Predictors included age, sex, education, and amyloid PET mean cortical SUVR calculated using either a cerebellar reference region (mcSUVRcb), a cerebral white matter reference region (mcSUVRwm), or both. Six modeling approaches, partial least squares, regression tree, elastic net, k-nearest neighbors, random forest, and support vector machine, were evaluated using training and independent testing datasets. Model performance was evaluated on independent testing data using complementary measures of estimation accuracy and explained variance.

Results

Across the full cohort and within diagnostic subgroups, adding amyloid PET measures to demographic variables improved estimation of HCI. Models including mcSUVRwm consistently estimated HCI more accurately and explained more variance than corresponding models including mcSUVRcb alone. Models including both amyloid PET measures achieved the best or near-best performance, suggesting that cerebellar- and white-matter-referenced SUVRs may contain complementary information.

Discussion

Because the analyses were cross-sectional and did not include tau PET, these findings should be interpreted as association-based estimation rather than evidence for a direct amyloidmediated neurodegenerative pathway.

Conclusion

Amyloid PET improves cross-sectional estimation of AD-related glucose hypometabolism beyond demographic covariates, particularly when amyloid burden is quantified using a cerebral white matter reference region.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.